Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies

Veterinary Immunology and Immunopathology

Volumn 99, Issue 1-2, 2004, Pages 25-37

  Bull, Marta E ^a   Vahlenkamp, Thomas W ^a   Dow, Janet L ^a   Collisson, Ellen W ^b   Winslow, Barbara J ^c   Phadke, Anagha P ^b   Tompkins, Mary B ^a   Tompkins, Wayne A F ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Schering Plough Anim Hlth Corp   (United States)

Author keywords

Apoptosis; B7 co stimulatory molecules; CTLA4; FIV; IL2

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CAT; CONTROLLED STUDY; FELINE IMMUNODEFICIENCY VIRUS; FLOW CYTOMETRY; LYMPH NODE CELL; LYMPHOCYTE CULTURE; MEASUREMENT; NICK END LABELING; NONHUMAN; PROTEIN PROTEIN INTERACTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; VIREMIA;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD; ANTIGENS, CD86; APOPTOSIS; CATS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; IMMUNODEFICIENCY VIRUS, FELINE; IN SITU NICK-END LABELING; INTERLEUKIN-2; LYMPH NODES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SPECIFIC PATHOGEN-FREE ORGANISMS;

ANIMALIA; FELIDAE; FELINE IMMUNODEFICIENCY VIRUS; FELIS CATUS;

EID: 2142639336     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2004.01.010     Document Type: Article

References (74)

1. Abe K., Takasaki Y., Ushiyama C., Asakawa J., Fukazawa T., Seki M., Hirashima M., Ogaki M., Hashimoto H. Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus. J. Clin. Immunol. 19:1999;58-66
2. Adachi Y., Oyaizu N., Than S., McCloskey T.M., Pahwa S. IL2 rescues in vitro lymphocyte apoptosis in patients with HIV infection: correlation with its ability to block culture induced down-modulation of Bcl-2. J. Immunol. 157:1996;4184-4193
3. Ascher M.S., Sheppard H.W. AIDS as immune system activation: a model for pathogenesis. Clin. Exp. Immunol. 73:1988;165-167
4. Azuma M., Yssel H., Phillips J.H., Spits H., Lanier L.L. Functional expression of B7/BB1 on activated T lymphocytes. J. Exp. Med. 177:1993;845-850
5. + T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J. Exp. Med. 185:1997;55-64
6. Badley A.D., Parato K., Cameron D.W., Kravcik S., Phenix B.N., Ashby D., Kumar A., Lynch D.H., Tschopp J., Angel J.B. Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Diff. 6:1999;420-432
7. Barnaba V., Watts C., de Boer M., Lane P., Lanzavecchia A. Professional presentation of antigen by activated human T cells. Eur. J. Immunol. 24:1994;71-75
8. Brunner M.C., Chambers C.A., Chan F.K., Hanke J., Winoto A., Allison J.P. CTLA-4-mediated inhibition of early events of T cell proliferation. J. Immunol. 162:1999;5813-5820
9. + cell phenotype mediating antiviral activity in feline immunodeficiency virus-infected cats is characterized by reduced surface expression of the CD8-alpha chain. J. Immunol. 178:1998;968-977
10. + T cells induces anergy and apoptosis. J. Immunol. 160:1998;3655-3665
11. Chai J.-G., Bartok I., Chandler P., Vendetti S., Antoniou A., Dyson J., Lechler R. Anergic T cells act as suppressor cells in vitro and in vivo. Eur. J. Immunol. 29:1999;686-692
12. Corry D.B., Reiner S.L., Linsley P.S., Locksley R.M. Differential effects of blockade of CD28-B7 on the development of Th1 or Th2 effector cells in experimental leishmaniasis. J. Immunol. 153:1994;4142-4148
13. English R.V., Johnson C.M., Gebhard D.H., Tompkins M.B. In vivo tropism of feline immunodeficiency virus. J. Virol. 67:1993;5175-5186
14. English R.V., Nelson P., Johnson C.M., Nasisse M., Tompkins W.A.F., Tompkins M.B. Development of clinical disease in cats experimentally infected with feline immunodeficiency virus. J. Infect. Dis. 170:1994;543-552
15. Finkel T.H., Tudor-Williams G., Banda N.K., Cotton M.F., Curiel T., Monks C., Baba T.W., Ruprecht R.M., Kupfer A. Apoptosis occurs predominately in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1:1995;129-134
16. Freeman G.J., Borriello F., Hodes R.J., Reiser H., Hathcock K.S., Laszlo G., McKnight A.J., Kim J., Du L., Lombard D.B., et al. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice. Science. 262:1993;907-909
17. Freeman G.J., Boussiotis V.A., Anumanthan A., Bernstein G.M., Ke X.Y., Rennert P.D., Gray G.S., Gribben J.G., Nadler L.M. B7-1 and B7-2 do not deliver identical co-stimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:1995;523-532
18. + T cells by a Fas-independent mechanism. J. Exp. Med. 187:1998;1113-1122
19. Gebhard D.H., Dow J.L., Childers T.A., Alvelo J.I., Tompkins M.B., Tompkins W.A. Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats. J. Infect. Dis. 180:1999;1503-1513
20. Golding H., Shearer G.M., Hillman K., Lucas P., Manischewitz J., Zajac R.A., Clerici M., Gress R.E., Boswell R.N., Golding B. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. J. Clin. Invest. 83:1989;1430-1435
21. Gougeon M.L., Lecoeur H., Dulioust A., Enouf M.G., Crouvoiser M., Goujard C., Debord T., Montagnier L. Programmed cell death in peripheral lymphocytes from HIV-infected persons: increased susceptibility to apoptosis of CD4 and CD8 T cells correlates with lymphocyte activation and with disease progression. J. Immunol. 156:1996;3509-3520
22. Grabar S., Le Moing V., Goujard C., Leport C., Kazatchkine M.D., Costagliola D., Weiss L. Clinical outcome of patients with HIV-1 infection according to immunologic and virologic response after 6 months of highly active antiretroviral therapy. Ann. Intern. Med. 133:2000;401-410
23. Gribben J.G., Freeman G.J., Boussiotis V.A., Rennert P., Jellis C.L., Greenfield E., Barber M., Restivo V.A. Jr., Xiaoyan K., Gray G.S., Nadler L.M. CTLA-4 mediates antigen specific apoptosis of human T cells. Proc. Natl. Acad. Sci. U.S.A. 92:1995;811-815
24. Gruters R.A., Terpstra F.G., De Jong R., Van Noesel C.J., Van Lier R.A., Miedema F. Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS. Eur. J. Immunol. 20:1990;1039-1044
25. Guiot A.L., Rigal D., Chappuis G. Spontaneous programmed cell death (PCD) process of lymphocytes of FIV-infected cats: pharmacological modulation in vitro. Int. J. Immunopharmacol. 19:1997;167-179
26. Guiot A.L., Rigal D., Chappuis G. Spontaneous programmed cell death (PCD) process of lymphocytes of FIV-infected cats: cellular targets and modulation. Vet. Immunol. Immunopathol. 58:1997;93-106
27. Haffar O.K., Smithgall M.D., Bradshaw J., Brady B., Damle N.K., Linsley P.S. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors. Proc. Natl. Acad. Sci. U.S.A. 90:1993;11094-11098
28. Hofmann B., Odum N., Platz P., Ryder L.P., Svejgaard A., Neilsen J.O. Immunological studies in acquired immunodeficiency syndrome. Functional studies of lymphocyte subpopulations. Scand. J. Immunol. 23:1986;669-678
29. Holznagel E., Hofmann-Lehmann R., Leutenegger C.M., Allenspach K., Huettner S., Forster U., Niederer E., Joller H., Willett B.J., Hummel U., Rossi G.L., Schupbach J., Lutz H. The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression. J. Virol. 72:1998;9025-9033
30. + T cells. J. Immunol. 165:2000;5062-5068
31. Kochli C., Wendland T., Frutig K., Grunow R., Merlin S., Pichler J.W. CD80 and CD86 co-stimulatory molecules on circulating T cells of HIV infected individuals. Immunol. Lett. 65:1999;197-201
32. Krummel M.F., Allison J.P. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182:1995;459-465
33. Krummel M.F., Allison J.P. CTLA-4 engagement inhibits IL2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183:1996;2533-2540
34. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. B7-1 and B7-2 co-stimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. J. Immunol. 80:1995;707-718
35. Lanzavecchia A., Roosnek E., Gregory T., Berman P., Abrignani S. T cells can present antigens such as HIV gp120 targeted to their own surface molecules. Nature. 334:1988;530-532
36. Lanzavecchia A., Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science. 290:2000;92-97
37. Leng Q., Borkow G., Weisman Z., Stein M., Kalinkovich A., Bentwich Z. Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection. J. Acq. Immun. Def. Synd. 27:2001;389-397
38. Leng Q., Bentwich Z., Magen E., Kalinkovich A., Borkow G. CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention. AIDS. 16:2002;519-529
39. Leutenegger C.M., Klein D., Hofmann-Lehmann R., Mislin C., Hummel U., Boni J., Boretti F., Guenzburg W.H., Lutz H. Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system. J. Virol. Meth. 78:1999;105-116
40. Levy J.K., Ritchey J.W., Rottman J.B., Davidson M.G., Liang Y.H., Jordan H.L., Tompkins W.A., Tompkins M.B. Elevated interleukin-10-to-interleukin-12 ratio in feline immunodeficiency virus-infected cats predicts loss of type 1 immunity to Toxoplasma gondii. J. Infect. Dis. 178:1998;503-511
41. + T cells from HIV-infected persons. J. Immunol. 153:1994;412-420
42. Lewis D.E., Ng Tang D.S., Wang X., Kozinetz C. Costimulatory pathways mediate monocyte-dependent lymphocyte apoptosis in HIV. Clin. Immunol. 90:1999;302-312
43. Linsley P.S., Brady W., Grosmarie L., Aruffo A., Damle N.K., Ledbetter J.A. Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J. Exp. Med. 173:1991;721-730
44. Linsley P.S., Nadler S.G., Bajorath J., Peach R., Leung H.T., Rogers J., Bradshaw J., Stebbins M., Leytze G., Brady W., Malacko A.R., Marquardt H., Shaw S.-Y. Binding stoichiometry of the cytotoxic T lymphocyte associated molecule-4 (CTLA4): a disulfide-linked homodimer binds two CD86 molecules. J. Biol. Chem. 270:1995;15417-15424
45. Liu Z., Hultin L.E., Cumberland W.G., Hultin P., Schmid I., Matud J.L., Detels R., Giorgi J.V. Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up. Cytometry. 26:1996;1-7
46. Lyerly H.K., Matthews T.J., Langlois A.J., Bolognesi D.P., Weinhold K.J. Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack. Proc. Natl. Acad. Sci. U.S.A. 84:1987;4601-4605
47. Muro-Cacho C.A., Pantaleo G., Fauci A.S. Analysis of apoptosis in lymph nodes of HIV-infected persons: intensity of apoptosis correlates with general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J. Immunol. 154:1995;5555-5566
48. Obaya A.J., Sedivy J.M. Regulation of cyclin-Cdk activity in mammalian cells. Cell Mol. Life Sci. 59:2002;126-142
49. Paiardini M., Galati D., Cervasi B., Cannavo G., Galluzzi L., Montroni M., Guetard D., Magnani M., Piedimonte G., Silvestri G. Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus infected individuals. J. Virol. 75:2001;10843-10855
50. Perkins D., Wang Z., Donovan C., He H., Mark D., Guan G., Wang Y., Walunas T., Bluestone J., Listman J., Finn P.W. Regulation of CTLA-4 expression during T cell activation. J. Immunol. 156:1996;4154-4159
51. Regamey N., Harr T., Battegay M., Erb P. Down regulation of Bcl-2 but not Bax or Bcl-x is associated with T lymphocyte apoptosis in HIV-infection and restored by antiretroviral therapy or by interleukin-2. AIDS Res. Hum. Retrov. 159:1999;803-810
52. Rideout B.A., Moore P.F., Pedersen N.C. Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus. Vet. Immunol. Immunopathol. 35:1992;71-81
53. Sansom D.M., Hall N.D. B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro. Eur. J. Immunol. 23:1993;295-298
54. Sansom D.M. CD28, CTLA-4 and their ligands: who does what and to whom? Immunology. 101:2000;169-177
55. Saraste A. Morphological criteria and detection of apoptosis. Herz. 24:1999;189-195
56. + T-lymphocytes induced by CTLA-4 crosslinking. Proc. Natl. Acad. Sci. U.S.A. 95:1998;10083-10088
57. Schneider H., Martin M., Agarraberes F.A., Yin L., Rapoport I., Kirchhausen T., Rudd C.E. Cytolytic T lymphocyte-associated antigen-4 and the TCR zeta/CD3 complex, but not CD28, interact with clathrin adaptor complexes AP-1 and AP-2. J. Immunol. 163:1999;1868-1879
58. Schwartz R.H. A cell culture model for T lymphocyte clonal anergy. Science. 248:1990;1349-1356
59. Schwartz R.H. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71:1992;1065
60. Shearer G., Clerici M. Early T-helper defects in HIV infection. AIDS. 5:1991;245-251
61. Siliciano R.F., Lawton T., Knall C., Karr R.W., Berman P., Gregory T., Reinherz E.L. Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion. Cell. 54:1988;561-575
62. + T cells in HIV infection. Clin. Exp. Immunol. 115:1999;451-457
63. Taams L.S., van Eden W., Wauben M.H.M. Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions. Eur. J. Immunol. 29:1999;1543-1550
64. Takasaki Y., Ogaki M., Abe K., Takeuchi K., Ondo S., Tokano Y., Kobayashi S., Sekigawa I., Tsuda H., Hashimoto H. Expression of co-stimulatory molecule CD80 on peripheral blood T cells in patients with systemic lupus erythematosus. J. Rheumatol. 25:1998;1085-1091
65. Teppler H., Kaplan G., Smith K.A., Montana A.L., Meyn P., Cohn Z.A. Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection. J. Exp. Med. 177:1993;483-492
66. Tompkins M.B., Gebhard D.H., Bingham H.R., Hamilton M.J., Davis W.C., Tompkins W.A.F. Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat. Vet. Immunol. Immunopathol. 26:1990;305-317
67. Tompkins M.B., Nelson P.D., English R.V., Novotney C. Early events in the immunopathogenesis of feline retrovirus infections. JAVMA. 199:1991;1311-1315
68. + T cell apoptosis. J. Infect. Dis. 185:2002;1077-1093
69. Van Noesel C.J., Gruters R.A., Terpstra F.G., Schellekens P.T., van Lier R.A., Miedema F. Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men. J. Clin. Invest. 86:1990;293-299
70. Wells A.D., Walsh M.C., Bluestone J.A., Turka L.A. Signalling through CD28 and CTLA4 controls two distinct forms of T cell anergy. J. Clin. Invest. 108:2001;204-895
71. + T cells. Eur. J. Immunol. 26:1996;1700-1706
72. Wood R., Montoya J.G., Kundu S.K., Schwartz D.H., Merigan T.C. Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study. J. Infect. Dis. 167:1993;519-525
73. Wyss-Coray T., Mauri-Hellweg D., Baumann K., Bettens F., Grunow R., Pichler W.J. The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions. Eur. J. Immunol. 23:1993;2175-2180
74. Yang J.S., English R., Ritchey J.W., Davidson M.G., Wasmosen T., Levy J.K., Gebhard D.H., Tompkins M.B., Tompkins W.A.F. Molecularly cloned feline immunodeficiency virus NCSU1 JSY3 induces immunodeficiency in specific pathogen-free cats. J. Virol. 70:1996;3011-3017